65 /100
HIGH RISK
Score updated Jul 14, 2026

MRAI — Marpai, Inc. Dilution Risk Tracker

Track MRAI dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MRAI — Get alerts when the score changes →

As of July 14, 2026, Marpai, Inc. (MRAI) has a DilutionWatch DilutionScore of 65/100, rated HIGH dilution risk. Marpai, Inc. has a market capitalization of $18.92M, 25.29M shares outstanding. Key dilution vectors include 140.0K outstanding warrants, approximately 0 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
95
📊 Float Risk
17
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
59%
🔄 Reverse Split 70%
• 50-day avg $0.32 below $1 exchange minimum
• Only 0 months cash — financial pressure
💰 Capital Raise 55%
• Critical: only 0.2 months cash remaining
🔁 Convertible Conversion 40%
• Significant convertible debt: 26% potential dilution
• Elevated convertible risk (60/100)
🔔 Track MRAI — Get forecast alerts →

💹 Market Data

Market Cap$18.92M
Shares Outstanding25.29M
FloatN/A
Cash$201.0K
Debt$19.88M
Short InterestN/A

🏛 Institutional Holdings

4.1% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
🔔 Track MRAI for full holder detail →

📉 Short Interest

Short Interest6.4K
Days to Cover1.0
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2023
8-K 8K EVENT Feb 13, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for MRAI Shareholders

Marpai, Inc. (MRAI) has a DilutionScore of 65/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

DilutionWatch tracks 140,000 outstanding warrants for MRAI. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window. Cash runway is a key watch item: MRAI has approximately 0 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for MRAI in real-time, scanning EDGAR every 60 seconds. Recent 8-K filings are present; material events disclosures can sometimes precede or accompany capital raises. The DilutionWatch screener shows real-time score changes for MRAI alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track MRAI Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MRAI — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for MRAI
📊 MRAI FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MRAI Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.